NCT01450605View on ClinicalTrials.gov

Korean Post-marketing Surveillance for Reyataz®

CompletedOBSERVATIONAL
Enrollment

601

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
HIV-1
Interventions
DRUG

No Intervention

Patients are previously on Reyataz® treatment or initiated Reyataz® for the first time

Trial Locations (1)

110-756

Local Institution, Seoul

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT01450605 - Korean Post-marketing Surveillance for Reyataz® | Biotech Hunter | Biotech Hunter